Open AccessEarly Intervention in Multiple Myeloma—Exploring New Frontiers
Author(s) -
Shaji Kumar
Publication year - 2018
Publication title -
oncology and hematology review
Language(s) - English
Resource type - Journals
eISSN - 2052-3823
pISSN - 2052-3815
DOI - 10.17925/ohr.2018.14.1.12
Subject(s) - multiple myeloma , life expectancy , disease , intervention (counseling) , medicine , intensive care medicine , immunology , environmental health , nursing , population
The progress that has been made in myeloma during the past decade has been remarkable, and paralleled by few other cancers, if any. This has come through a combination of better understanding of the disease biology, introduction of new drug classes, development of rational and highly effective combinations, extended duration of therapy, and better supportive care. However, we are still far from being able to label myeloma as a curable disease given the inability to predict who, if any, will be able to have a normal life expectancy after a diagnosis of myeloma. We clearly need a different approach to achieve this elusive goal. What might that be?